Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-1,637
Closed -$513K – 166
2017
Q3
$513K Hold
1,637
– – 0.1% 117
2017
Q2
$444K Hold
1,637
– – 0.09% 122
2017
Q1
$448K Sell
1,637
-1,056
-39% -$299K 0.09% 118
2016
Q4
$764K Buy
2,693
+146
+6% +$43.3K 0.15% 97
2016
Q3
$797K Buy
2,547
+15
+0.6% +$4.44K 0.16% 98
2016
Q2
$612K Sell
2,532
-2
-0.1% -$527 0.13% 110
2016
Q1
$660K Hold
2,534
– – 0.14% 108
2015
Q4
$776K Sell
2,534
-90
-3% -$25.9K 0.17% 97
2015
Q3
$766K Sell
2,624
-675
-20% -$223K 0.17% 97
2015
Q2
$1.33M Hold
3,299
– – 0.25% 89
2015
Q1
$1.39M Hold
3,299
– – 0.26% 88
2014
Q4
$1.12M Buy
3,299
+125
+4% +$40.4K 0.21% 92
2014
Q3
$1.05M Sell
3,174
-100
-3% -$33K 0.2% 93
2014
Q2
$1.03M Sell
3,274
-350
-10% -$105K 0.18% 96
2014
Q1
$1.11M Hold
3,624
– – 0.21% 92
2013
Q4
$1.01M Sell
3,624
-97
-3% -$25.1K 0.18% 97
2013
Q3
$896K Hold
3,721
– – 0.18% 96
2013
Q2
$801K Buy
+3,721
New +$795K 0.16% 97

Other funds holding BIIB

Woodstock Corp's BIIB Position: Q4 2017 in Review

Woodstock Corp sold out of Biogen (BIIB) in Q4 2017, closing a stake of 1,637 shares — an estimated $513K sold.

Woodstock Corp first reported a position in BIIB in Q2 2013 and held it in 18 quarters. The position peaked at $1.39M in Q1 2015. 1,123 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Woodstock Corp reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
  • Woodstock Corp sold 1,637 Biogen shares in Q4 2017, an estimated $513K.
  • Woodstock Corp first reported a position in Biogen in Q2 2013 and held it in 18 quarters.
  • Woodstock Corp's Biogen position peaked at $1.39M in Q1 2015.
  • 1,123 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Woodstock Corp's 13F filing for Q4 2017, filed 24 Jan 2018.